National Health Investors (NYSE:NHI – Get Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided EPS guidance of $4.32-$4.42 for the period. The company issued revenue guidance of -.
Shares of National Health Investors stock traded down $0.39 during trading on Wednesday, hitting $56.84. 3,035 shares of the company’s stock traded hands, compared to its average volume of 281,326. The company has a debt-to-equity ratio of 0.84, a current ratio of 23.40 and a quick ratio of 23.40. National Health Investors has a 1 year low of $50.22 and a 1 year high of $69.23. The stock has a market capitalization of $2.61 billion, a P/E ratio of 31.08 and a beta of 0.97. The business has a 50-day simple moving average of $55.87 and a 200-day simple moving average of $55.97.
National Health Investors (NYSE:NHI – Get Rating) last announced its earnings results on Monday, May 9th. The real estate investment trust reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.63 by ($0.45). The firm had revenue of $71.33 million during the quarter, compared to analysts’ expectations of $73.06 million. National Health Investors had a return on equity of 5.55% and a net margin of 29.35%. The company’s revenue for the quarter was down 11.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.24 earnings per share. On average, equities analysts predict that National Health Investors will post 4.45 earnings per share for the current fiscal year.
Several brokerages have issued reports on NHI. BMO Capital Markets dropped their target price on National Health Investors from $63.00 to $61.00 and set an outperform rating on the stock in a research report on Tuesday, April 19th. StockNews.com started coverage on National Health Investors in a research report on Thursday, March 31st. They set a hold rating on the stock. Zacks Investment Research raised National Health Investors from a strong sell rating to a hold rating in a research report on Friday, May 13th. Finally, Credit Suisse Group started coverage on National Health Investors in a research report on Tuesday, February 1st. They set an underperform rating and a $51.00 price objective on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, National Health Investors presently has an average rating of Hold and an average price target of $62.00.
Institutional investors and hedge funds have recently modified their holdings of the stock. Schonfeld Strategic Advisors LLC increased its stake in National Health Investors by 24.3% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 9,326 shares of the real estate investment trust’s stock worth $536,000 after acquiring an additional 1,826 shares during the last quarter. Hsbc Holdings PLC increased its stake in National Health Investors by 27.8% in the 1st quarter. Hsbc Holdings PLC now owns 9,014 shares of the real estate investment trust’s stock worth $533,000 after acquiring an additional 1,962 shares during the last quarter. LPL Financial LLC increased its stake in National Health Investors by 23.9% in the 4th quarter. LPL Financial LLC now owns 8,242 shares of the real estate investment trust’s stock worth $474,000 after acquiring an additional 1,589 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. bought a new stake in National Health Investors in the 1st quarter worth approximately $453,000. Finally, Nelson Van Denburg & Campbell Wealth Management Group LLC bought a new position in shares of National Health Investors during the 1st quarter valued at approximately $447,000. 63.53% of the stock is currently owned by institutional investors.
About National Health Investors (Get Rating)
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
- Get a free copy of the StockNews.com research report on National Health Investors (NHI)
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Dynatrace: Fundamentals are Positive While Being Punished
- Analog Devices Is Ready To Scale New Highs Despite Tech Wreck
- Now’s The Time To Buy Disney (NYSE: DIS)
- Target Follows Walmart Lower In A Downward Spiral Of Inflation
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.